Two Labs, an industry-leading pharma and life science services company, announced at Asembia’s 2018 Specialty Pharmacy Summit that Anita Dopkosky, a pharmaceutical industry executive, has joined the Commercialization team as Vice President of Specialty Pharmacy.
Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.
Excellere Partners, a Denver-based private equity firm focused on partnering with entrepreneurs and management teams, announced today that it has made a strategic investment in Two Labs Marketing, a leading provider of product commercialization solutions to pharmaceutical manufacturers, offering strategic consulting and implementation services throughout the full product lifecycle.
wo Labs Marketing, LLC, a Columbus-based consulting company, announced it is changing its name to Two Labs, LLC, a Pharma Services consulting company, to better reflect its expanded suite of offerings.
Pennside Partners extends a warm welcome to Tom Perkins, who has been hired as a Director based out of our Zurich office. Tom brings 14 years of pharmaceutical consulting experience to Pennside.
Alderley Edge, United Kingdom – As a result of expanding business and a desire to better serve its European client base, Pennside Partners today announced the opening of a new office in Alderley Edge, UK, 25 KM south of Manchester.
Pennside Partners, Ltd. is a leading business development consulting firm serving the pharmaceutical, biotechnology, and medical device sectors worldwide.
The annual European meeting offers insights into new data from ongoing clinical trials as well as a chance to discuss the implications of recently reported trial outcomes presented a few short months ago at ASCO.
For those of us taking an interest in Biotech and Drug Development the largest release of new clinical data is just around the corner at the annual American Society of Clinical Oncology (ASCO) meeting to be held in Chicago starting on May 31.
